Journal ArticleOPEN ACCESS

Targeting high circulating dipeptidyl peptidase 3 in circulatory failure

Critical Care (2025) 29(1)
DOI: 10.1186/s13054-025-05545-x
11Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Circulating dipeptidyl peptidase 3 is a new biomarker linked to circulatory failure prognosis and pathophysiology and is a potential actionable therapeutic target. In this short review intended for the clinician, a question-and-answer format provides key insights on the nature of this biomarker and the therapeutical potential of its targeted inhibition in critically ill patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Picod, A., Azibani, F., Harjola, V. P., Karakas, M., Kimmoun, A., Levy, B., … Mebazaa, A. (2025). Targeting high circulating dipeptidyl peptidase 3 in circulatory failure. Critical Care, 29(1). https://doi.org/10.1186/s13054-025-05545-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free